Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;7(4):293-9.
doi: 10.2450/2009.0071-08.

Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria

Fiekumo Igbida Buseri  1 , Musa Abidemi Muhibi, Zaccheaus Awortu Jeremiah
Affiliations

Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, south-west Nigeria

Fiekumo Igbida Buseri et al. Blood Transfus. 2009 Oct.

Abstract

Background: Transfusion-transmissible infectious agents such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), hepatitis C virus (HCV) and syphilis are among the greatest threats to blood safety for transfusion recipients and pose a serious public health problem. This cross-sectional study was undertaken with the aim of determining the seroprevalence of HIV, HCV, hepatitis B surface antigen (HBsAg) and syphilis and correlates the findings with sex and age to ascertain the associations, if any, in the occurrence of the pathogens.

Materials and methods: HBsAg, antibodies to Treponema pallidum and HCV were determined using Clinotech test strips. Antibodies to HIV types 1 and 2 were screened with Determine and Immunocomb. All the reactive samples were confirmed using enzyme-linked immunosorbent assays. Antibodies to Treponema pallidum were confirmed with a Treponema pallidum haemagglutination test.

Results: A total of 1,410 apparently healthy prospective blood donors aged between 18 and 64 years (mean+/-SD, 32.58 +/- 10.24 years) who presented for blood donation at the Ladoke Akintola University of Technology Teaching Hospital Blood Bank, Osogbo were studied. The male:female ratio was 6:1. Of the prospective blood donors, 406 (28.8%) had serological evidence of infection with at least one infectious marker and 36 (2.6%) had dual infections. The overall seroprevalence of HBsAg, HIV, HCV and syphilis was found to be 18.6%, 3.1%, 6.0% and 1.1%, respectively. The highest prevalences of HBsAg, HIV, HCV and syphilis infections occurred among commercial blood donors and those aged 18 to 47 years old, the most sexually active age group. There were no significant associations between pathogens except for syphilis and HIV (p > 0.001).

Conclusion: The high seroprevalence of blood-borne pathogens among prospective blood donors in Osogbo, Nigeria calls for mandatory routine screening of blood donors for HBV, HIV, HCV and syphilis.

Keywords: Nigeria; Osogbo; Transfusion-transmissible disease markers; blood donors; prevalence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Distribution and seroprevalence of TTIAs according to age groups
Figure 2
Figure 2
Distribution of infectious disease markers based on types of donation
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. World Health Organization (WHO) Blood Safety Strategy for the African Region. Brazzaville, World Health Organization, Regional Office for Africa (WHO AFR /RC51/9 Rev.1). 2002
    1. World Health Organization (WHO) Status of blood safety in the WHO African Region: Report of the 2004 Survey WHO Regional Office for Africa, Brazzaville 20071–25.
    1. Kitchen AD, Barbara JAJ. Transfusion transmitted infections. In: Murphy MF, Pamphilon DH, editors. Practical Transfusion Medicine. Blackwell Science; Oxford: 2001. pp. 192–210.
    1. Holmberg J. Activities Relating to Global Blood Safety at the Department of Health and Human Services. USA. 2006. pp. 1–5.
    1. Burnouf T, Radesevich M. Reducing the risk of infection from plasma products: specific preventive strategies. Blood Rev. 2000;14:94–110. - PubMed

MeSH terms